Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Yoshizumi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Respiratory Investigation|May 9, 2020
Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependenceRika Hashimoto, Hiromi Tomioka, Takamasa Wada, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Diffuse Pulmonary Ossification with Connective Tissue Weakness Potentially Due to Vascular Ehlers-Danlos SyndromeYuko Yoshizumi, Hiromi Tomioka, Eiji Katsuyama, et al.
Journal of Anesthesia|November 10, 2022
Deep breathing alleviates propofol-induced pain: a prospective, randomized, single-blind studyKatsuaki Tanaka, Yuko Yoshizumi, Taku Hamada, et al.
Respiratory Investigation|February 24, 2019
Ten-year experience of smoking cessation in a single center in JapanHiromi Tomioka, Takamasa Wada, Masatoshi Yamazoe, et al.
Investigational New Drugs|January 18, 2018
Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case reportKenta Ogawa, Jiro Ito, Daichi Fujimoto, et al.
Pathology International|January 18, 2018
Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Respiratory Investigation|May 9, 2020
Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependenceRika Hashimoto, Hiromi Tomioka, Takamasa Wada, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Diffuse Pulmonary Ossification with Connective Tissue Weakness Potentially Due to Vascular Ehlers-Danlos SyndromeYuko Yoshizumi, Hiromi Tomioka, Eiji Katsuyama, et al.
Journal of Anesthesia|November 10, 2022
Deep breathing alleviates propofol-induced pain: a prospective, randomized, single-blind studyKatsuaki Tanaka, Yuko Yoshizumi, Taku Hamada, et al.
Respiratory Investigation|February 24, 2019
Ten-year experience of smoking cessation in a single center in JapanHiromi Tomioka, Takamasa Wada, Masatoshi Yamazoe, et al.
Investigational New Drugs|January 18, 2018
Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case reportKenta Ogawa, Jiro Ito, Daichi Fujimoto, et al.
Pathology International|January 18, 2018
Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
JTO Clinical and Research Reports|April 6, 2026
Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED AnalysisMasashi Ishihara, Takahisa Kawamura, Yukiko Namba, et al.
Pageof 1